ID L_MUMPM Reviewed; 2261 AA. AC P30929; Q783V6; DT 01-JUL-1993, integrated into UniProtKB/Swiss-Prot. DT 01-JUL-1993, sequence version 1. DT 02-SEP-2026, entry version 128. DE RecName: Full=RNA-directed RNA polymerase L; DE Short=Protein L; DE AltName: Full=Large structural protein; DE AltName: Full=Replicase; DE AltName: Full=Transcriptase; DE Includes: DE RecName: Full=RNA-directed RNA polymerase; DE EC=2.7.7.48 {ECO:0000250|UniProtKB:P28887}; DE Includes: DE RecName: Full=GTP phosphohydrolase {ECO:0000250|UniProtKB:P03523}; DE EC=3.6.1.- {ECO:0000250|UniProtKB:P03523}; DE Includes: DE RecName: Full=GDP polyribonucleotidyltransferase {ECO:0000305}; DE EC=2.7.7.88 {ECO:0000250|UniProtKB:P03523}; DE AltName: Full=PRNTase {ECO:0000305}; DE Includes: DE RecName: Full=mRNA cap methyltransferase {ECO:0000305}; DE AltName: Full=mRNA (guanine-N(7)-)-methyltransferase {ECO:0000250|UniProtKB:P03523}; DE Short=G-N7-MTase {ECO:0000250|UniProtKB:P03523}; DE AltName: Full=mRNA (nucleoside-2'-O-)-methyltransferase {ECO:0000250|UniProtKB:P03523}; DE Short=N1-2'-O-MTase {ECO:0000250|UniProtKB:P03523}; GN Name=L; OS Mumps virus genotype B (strain Miyahara vaccine) (MuV). OC Viruses; Riboviria; Orthornavirae; Negarnaviricota; Haploviricotina; OC Monjiviricetes; Mononegavirales; Paramyxoviridae; Rubulavirinae; OC Orthorubulavirus; Orthorubulavirus parotitidis; Mumps orthorubulavirus. OX NCBI_TaxID=11171; OH NCBI_TaxID=9606; Homo sapiens (Human). RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC RNA]. RX PubMed=1585659; DOI=10.1016/0042-6822(92)90555-4; RA Okazaki K., Tanabayashi K., Takeuchi K., Hishiyama M., Okazaki K., RA Yamada A.; RT "Molecular cloning and sequence analysis of the mumps virus gene encoding RT the L protein and the trailer sequence."; RL Virology 188:926-930(1992). RN [2] RP INTERACTION WITH THE HOST RUVBL1, AND INTERACTION WITH THE HOST RUVBL2. RX PubMed=31121004; DOI=10.1371/journal.ppat.1007749; RA Katoh H., Sekizuka T., Nakatsu Y., Nakagawa R., Nao N., Sakata M., Kato F., RA Kuroda M., Kidokoro M., Takeda M.; RT "The R2TP complex regulates paramyxovirus RNA synthesis."; RL PLoS Pathog. 15:e1007749-e1007749(2019). CC -!- FUNCTION: RNA-directed RNA polymerase that catalyzes the transcription CC of viral mRNAs, their capping and polyadenylation. The template is CC composed of the viral RNA tightly encapsidated by the nucleoprotein CC (N). The viral polymerase binds to the genomic RNA at the 3' leader CC promoter, and transcribes subsequently all viral mRNAs with a CC decreasing efficiency. The first gene is the most transcribed, and the CC last the least transcribed. The viral phosphoprotein acts as a CC processivity factor. Capping is concomitant with initiation of mRNA CC transcription. Indeed, a GDP polyribonucleotidyl transferase (PRNTase) CC adds the cap structure when the nascent RNA chain length has reached CC few nucleotides. Ribose 2'-O methylation of viral mRNA cap precedes and CC facilitates subsequent guanine-N-7 methylation, both activities being CC carried by the viral polymerase. Polyadenylation of mRNAs occur by a CC stuttering mechanism at a slipery stop site present at the end viral CC genes. After finishing transcription of a mRNA, the polymerase can CC resume transcription of the downstream gene. CC {ECO:0000250|UniProtKB:P03523}. CC -!- FUNCTION: RNA-directed RNA polymerase that catalyzes the replication of CC viral genomic RNA. The template is composed of the viral RNA tightly CC encapsidated by the nucleoprotein (N). The replicase mode is dependent CC on intracellular N protein concentration. In this mode, the polymerase CC replicates the whole viral genome without recognizing transcriptional CC signals, and the replicated genome is not caped or polyadenylated. CC {ECO:0000250|UniProtKB:P03523}. CC -!- CATALYTIC ACTIVITY: CC Reaction=RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + CC diphosphate; Xref=Rhea:RHEA:21248, Rhea:RHEA-COMP:14527, Rhea:RHEA- CC COMP:17342, ChEBI:CHEBI:33019, ChEBI:CHEBI:61557, ChEBI:CHEBI:140395; CC EC=2.7.7.48; Evidence={ECO:0000255|PROSITE-ProRule:PRU00539}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a 5'-end (5'-triphosphoguanosine)-adenylyl-adenylyl-cytidylyl- CC adenosine in mRNA + S-adenosyl-L-methionine = a 5'-end (5'- CC triphosphoguanosine)-(2'-O-methyladenylyl)-adenylyl-cytidylyl- CC adenosine in mRNA + S-adenosyl-L-homocysteine + H(+); CC Xref=Rhea:RHEA:65380, Rhea:RHEA-COMP:16797, Rhea:RHEA-COMP:16801, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, CC ChEBI:CHEBI:156482, ChEBI:CHEBI:156484; CC Evidence={ECO:0000250|UniProtKB:P03523}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a 5'-end triphospho-adenylyl-adenylyl-cytidylyl-adenosine in CC mRNA + GDP + H(+) = a 5'-end (5'-triphosphoguanosine)-adenylyl- CC adenylyl-cytidylyl-adenosine in mRNA + diphosphate; CC Xref=Rhea:RHEA:65436, Rhea:RHEA-COMP:16797, Rhea:RHEA-COMP:16799, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:58189, CC ChEBI:CHEBI:156484, ChEBI:CHEBI:156503; EC=2.7.7.88; CC Evidence={ECO:0000250|UniProtKB:P28887}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a 5'-end (5'-triphosphoguanosine)-(2'-O-methyladenylyl)- CC adenylyl-cytidylyl-adenosine in mRNA + S-adenosyl-L-methionine = a CC 5'-end (N(7)-methyl 5'-triphosphoguanosine)-(2'-O-methyladenylyl)- CC adenylyl-cytidylyl-adenosine in mRNA + S-adenosyl-L-homocysteine; CC Xref=Rhea:RHEA:65440, Rhea:RHEA-COMP:16798, Rhea:RHEA-COMP:16801, CC ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:156482, CC ChEBI:CHEBI:156483; Evidence={ECO:0000250|UniProtKB:P03523}; CC -!- CATALYTIC ACTIVITY: CC Reaction=GTP + H2O = GDP + phosphate + H(+); Xref=Rhea:RHEA:19669, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; CC Evidence={ECO:0000250|UniProtKB:P28887}; CC -!- SUBUNIT: Interacts with the P protein (By similarity). Interacts with CC host RUVBL1 and RUVBL2 (R2TP complex); this interaction regulates the CC viral transcription (PubMed:31121004). {ECO:0000250|UniProtKB:C0JJA4, CC ECO:0000269|PubMed:31121004}. CC -!- SUBCELLULAR LOCATION: Virion {ECO:0000250|UniProtKB:C0JJA4}. CC -!- SIMILARITY: Belongs to the paramyxovirus L protein family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D10575; BAA01432.1; -; Genomic_RNA. DR EMBL; AB040874; BAA94391.1; -; Genomic_RNA. DR PIR; A42548; A42548. DR AlphaFoldDB; P30929; -. DR SMR; P30929; -. DR KEGG; vg:1489763; -. DR Proteomes; UP000002331; Segment. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0003924; F:GTPase activity; ISS:UniProtKB. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0004482; F:mRNA 5'-cap (guanine-N7-)-methyltransferase activity; IEA:InterPro. DR GO; GO:0062105; F:RNA 2'-O-methyltransferase activity; IEA:RHEA. DR GO; GO:0003968; F:RNA-directed RNA polymerase activity; IEA:UniProtKB-KW. DR Gene3D; 3.40.50.12760; -; 1. DR InterPro; IPR039736; L_poly_C. DR InterPro; IPR026890; Mononeg_mRNAcap. DR InterPro; IPR014023; Mononeg_RNA_pol_cat. DR InterPro; IPR025786; Mononega_L_MeTrfase. DR InterPro; IPR016269; RNA-dir_pol_paramyxovirus. DR NCBIfam; TIGR04198; paramyx_RNAcap; 1. DR Pfam; PF14318; Mononeg_mRNAcap; 1. DR Pfam; PF00946; Mononeg_RNA_pol; 1. DR PIRSF; PIRSF000830; RNA_pol_ParamyxoV; 1. DR PROSITE; PS50526; RDRP_SSRNA_NEG_NONSEG; 1. DR PROSITE; PS51590; SAM_MT_MNV_L; 1. PE 1: Evidence at protein level; KW ATP-binding; Hydrolase; Magnesium; Metal-binding; Methyltransferase; KW mRNA capping; mRNA processing; Multifunctional enzyme; Nucleotide-binding; KW Nucleotidyltransferase; Reference proteome; RNA-directed RNA polymerase; KW S-adenosyl-L-methionine; Transferase; Viral RNA replication; Virion; Zinc. FT CHAIN 1..2261 FT /note="RNA-directed RNA polymerase L" FT /id="PRO_0000142730" FT DOMAIN 662..846 FT /note="RdRp catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00539" FT DOMAIN 1781..1994 FT /note="Mononegavirus-type SAM-dependent 2'-O-MTase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00923" FT REGION 630..651 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 919..1405 FT /note="PRNTase" FT /evidence="ECO:0000250|UniProtKB:C0JJA4" FT REGION 1222..1258 FT /note="priming-capping loop" FT /evidence="ECO:0000250|UniProtKB:P03523" FT ACT_SITE 1298 FT /note="Nucleophile; for GDP polyribonucleotidyltransferase" FT /evidence="ECO:0000250|UniProtKB:P03523" FT ACT_SITE 1792 FT /note="For mRNA (guanine-N(7)-)-methyltransferase and mRNA FT (nucleoside-2'-O-)-methyltransferase" FT /evidence="ECO:0000250|UniProtKB:Q06996" FT ACT_SITE 1917 FT /note="For mRNA (guanine-N(7)-)-methyltransferase and mRNA FT (nucleoside-2'-O-)-methyltransferase" FT /evidence="ECO:0000250|UniProtKB:Q06996" FT ACT_SITE 1953 FT /note="For mRNA (guanine-N(7)-)-methyltransferase and mRNA FT (nucleoside-2'-O-)-methyltransferase" FT /evidence="ECO:0000250|UniProtKB:P03523" FT ACT_SITE 1990 FT /note="For mRNA (guanine-N(7)-)-methyltransferase and mRNA FT (nucleoside-2'-O-)-methyltransferase" FT /evidence="ECO:0000250|UniProtKB:Q06996" FT BINDING 669 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_note="catalytic; for RNA-directed RNA polymerase FT activity" FT /evidence="ECO:0000250|UniProtKB:P28887" FT BINDING 779 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_note="catalytic; for RNA-directed RNA polymerase FT activity" FT /evidence="ECO:0000250|UniProtKB:P28887" FT BINDING 1142 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /ligand_note="structural" FT /evidence="ECO:0000250|UniProtKB:C0JJA4" FT BINDING 1174 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /ligand_note="structural" FT /evidence="ECO:0000250|UniProtKB:C0JJA4" FT BINDING 1187 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /ligand_note="structural" FT /evidence="ECO:0000250|UniProtKB:C0JJA4" FT BINDING 1190 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /ligand_note="structural" FT /evidence="ECO:0000250|UniProtKB:C0JJA4" FT BINDING 1372 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /ligand_note="structural" FT /evidence="ECO:0000250|UniProtKB:C0JJA4" FT BINDING 1374 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /ligand_note="structural" FT /evidence="ECO:0000250|UniProtKB:C0JJA4" FT BINDING 1379 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /ligand_note="structural" FT /evidence="ECO:0000250|UniProtKB:C0JJA4" FT BINDING 1380 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /ligand_note="structural" FT /evidence="ECO:0000250|UniProtKB:C0JJA4" FT BINDING 1811..1820 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255" SQ SEQUENCE 2261 AA; 256575 MW; A789F54BFC1EB5EB CRC64; MAGLNEILLP EVHLNSPIVR YKLFYYILHG QLPNDLEPDD LGPLANQNWK AIRAEESQVH ARLKQIRVEL IARIPSLRWT RSQREIAILI WPRILPILQA YDLRQSMQLP TVWEKLTQST VNLISDGLER VVLHISNQLT GKPNLFTRSR AGQDVKDYSI PSTRELSQIW FNNEWSGSVK TWLMIKYRMR QLITNQKTGE LTDLVTIVDT RSTLCIIAPE LVALYSNEHK ALTYLTFEMV LMVTDMLEGR LNVSSLCTAS HYLSPLKKRI EILLTLVDDL ALLMGDKVYG VVSSLESFVY AQLQYGDPVV DIKGTFYGFI CNEILDLLTE DNIFTEEEAN KVLLDLTSQF DNLSPDLTAE LLCIMRLWGH PTLTASQAAS KVRESMCAPK VLDFQTIMKT LAFFHAILIN GYRRSHNGIW PPTTLHGNAP KSLIEMRHDN SELKYEYVLK NWKSISMLRI HKCFDASPDE DLSIFMKDKA ISCPKQDWMG VFRRSLIKQR YRDANRPLPQ PFNRRLLLNF LEDDRFDPIK ELEYVTSGEY LRDPEFCASY SLKEKEIKAT GRIFAKMTKR MRSCQVIAES LLANHAGKLM RENGVVLDQL KLTKSLLTMN QIGIISEHSR RSTADNMTLA HSGSNKHRIN NSQFKKNKDS KHEMPDDGFE IAACFLTTDL TKYCLNWRYQ VIIPFARTLN SMYGIPHLFE WIHLRLMRST LYVGDPFNPP SDPTQLDLDT ALNDDIFIVS PRGGIEGLCQ KLWTMISIST IILSATEANT RVMSMVQGDN QAIAITTRVV RSLSHSEKKE QAYKASKLFF ERLRANNHGI GHHLKEQETI LSSDFFIYSK RVFYKGRILT QALKNVSKMC LTADILGDCS QASCSNLATT VMRLTENGVE KDLCYFLNAF MTIRQLCYDL VFPQTKSLSQ DITNAYLNHP ILISRLCLLP SQLGGLNFLS CSRLFNRNIG DPLVSAIADV KRLIKAGCLD IWVLYNILGR RPGKGKWSTL AADPYTLNID YLVPSKTFLK KHAQYTLMER SVNPMLRGVF SENAAEEEEE LAQYLLDREV VMPRVAHVIL AQSSCGRRKQ IQGYLDSTRT IIRYSLEVRP LSAKKLNTVI EYNLLYLSYN LEIIEKPNIV QPFLNAINVD TCSIDIARSL RKLSWATLLN GRPIEGLETP DPIELVHGCL IIGSDECEHC SSGDDKFTWF FLPKGIRLDN DPASNPPIRV PYIGSKTDER RVASMAYIKG ASVSLKSALR LAGVYIWAFG DTEESWQDAY ELASTRVNLT LEQLQSLTPL PTSANLVHRL DDGTTQLKFT PASSYAFSSF VHISNDCQVL EIDDQVTDSN LIYQQVMITG LALIETWNNP PINFSVYETT LHLHTGSSCC IRPVESCVVN PPLLPVPFIN VPQMNKFVYD PEPLSLLEME KIEDIAYQTR IGGLDQIPLL EKIPLLAHLT AKQMVNSITG LDEATSIVND AVVQADYTSN WISECCYTYI DSVFVYSGWA LLLELSYQMY YLRIQGIQGI LDYVYMTLRR IPGMAITGIS STISHPRILR RCINLDVIAP INSPHIASLD YTKLSIDAVM WGTKQVLTNI SQGIDYEIVV PSESQLTLSD RVLNLVARKL SLLAIIWANY NYPPKVKGMS PEDKCQALTT HLLQTVEYVE HIQIEKTNIR RMIIEPKLTA YPSNLFYLSR KLLNAIRDSE EGQFLIASYY NSFGYLEPIL MESKIFNLSS SESASLTEFD FILNLELSEA SLEKYSLPSL LMTAENMDNP FPQPPLHHVL RPLGLSSTSW YKTISVLNYI SHMKISDGAH LYLAEGSGAS MSLIETFLPG EIIWYNSLFN SGENPPQRNF APLPTQFIES VPYRLIQAGI AAGSGVVQSF YPLWNGNSDI TDLSTKTSVE YIIHKVGADT CALVHVDLEG VPGSMNSMLE RAQVHALLIT VTVLKPGGLL ILKASWEPFN RFSFLLTILW QFSSTIRILR SSYSDPNNHE VYIIATLAVD PTTSSFTTAL NRARTLNEQG FSLIPPELVS EYWRRRVEQG QIIQDCIDKV ISECVRDQYL ADNNIILQAG GTPSTRKWLD LPDYLSFNEL QSEMARLITI HLKEVIEILK GQSSDHDTLL FTSYNVGPLG KINTILRLIV ERILMYTVRN WCILPTQTRL TLRQSIELGE FRLRDVITPM EILKLSPNRK YLKSALNQST FNHLMGETSD ILLNRSYQKR IWKAIGCVIY CFGLLTPDVE DSERIDIDND IPDYDIHGDI I //